✦ LIBER ✦

Treatment of high risk myelodysplastic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)

✍ Scribed by Theofanis Economopoulos; Efstathios Papageorgiou; Nicholas Stathakis; Maria Constantinidou; Agapi Parharidou; Akrivi Kostourou; John Dervenoulas; Sotos Raptis

Book ID: 113240172
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 605 KB
Volume: 20
Category: Article
ISSN: 0145-2126
DOI: 10.1016/0145-2126(95)00169-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of “high risk” myelodysplastic

Treatment of “high risk” myelodysplastic syndromes (MDS) with idarubicin and cytosine arabinoside, supported by granulocyte-macrophage colony stimulating factor (GM-CSF)

✍ T. Economopoulos; E. Papageorgiou; A. Parharidou; M. Constantinidou; J. Dervenou 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Treatment of myelodysplastic syndromes w

Treatment of myelodysplastic syndromes with human granulocytic-macrophage colony stimulating factor (GM-CSF) or GM-CSF combined with low-dose cytosine arabinoside

✍ T. Economopoulos; E. Papageorgiou; N. Stathakis; N. Asprou; P. Karmas; J. Derven 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

Fludarabine, cytosine arabinoside, granu

Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes

✍ Donald W. Milligan; Keith Wheatley; Alan K. Burnett 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Treatment of myelodysplastic syndromes w

Treatment of myelodysplastic syndromes with human granulocytic-macrophage colony-stimulating factor (GM-CSF) or GM-CSF combined with low dose (ARA-C)

✍ T. Economopoulos; E. Papageorgiou; N. Asprou; P. Karmas; J. Dervenoulas; H. Bour 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Effects of low doses of recombinant huma

Effects of low doses of recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with myelodysplastic syndromes

✍ Elihu H. Estey; Razelle Kurzrock; Moshe Talpaz; Kenneth B. McCredie; Susan O'Bri 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 451 KB

Improvement of pneumonia and arthritis i

Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF)

✍ Lübbe, A. S. ;Schwella, N. ;Riess, H. ;Huhn, D. 📂 Article 📅 1990 🏛 Springer-Verlag ⚖ 198 KB